Acute Modulation of Renal Function in Microalbuminuric and Macroalbuminuric Insulin-Dependent Diabetic Patients

  • Hans-Henrik Parving
  • Eva Hommel
  • Elisabeth Mathiesen
Part of the Topics in Renal Medicine book series (TIRM, volume 6)


Recently, the impact on kidney function of hemodynamic factors (e.g., blood pressure), metabolic variables (e.g., blood glucose), vasoactive hormones (e.g., prostaglandins, angiotensin II), and protein loading or restriction has been elucidated in diabetic animals and man. This chapter reviews the influence of blood pressure, prostaglandins, and angiotensin II on urinary albumin excretion and glomerular filtration rate (GFR) in insulin-dependent diabetes mellitus (IDDM) patients with incipient and overt diabetic nephropathy.


Glomerular Filtration Rate Diabetic Nephropathy Arterial Blood Pressure Urinary Albumin Excretion IDDM Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285: 685–688, 1982.CrossRefGoogle Scholar
  2. 2.
    Parving H-H, Andersen AR, Smidt UM, Svendsen PAa: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1: 1175–1179, 1983.PubMedCrossRefGoogle Scholar
  3. 3.
    Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen E: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294: 1443–1447, 1987.CrossRefGoogle Scholar
  4. 4.
    Parving H-H, Andersen AR, Smidt UM,’ Friisberg B, Svendsen PAa: Reduced albuminuria during early and aggression antihypertensive treatment of insulin-dependent diabetics with diabetic nephropathy. Diabetes Care 4: 459–463, 1981.PubMedCrossRefGoogle Scholar
  5. 5.
    Parving H-H, Kastrup J, Smidt UM, Andersen AR, Feldt-Rasmussen B, Christiansen JS: Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 27: 547–552, 1984.PubMedCrossRefGoogle Scholar
  6. 6.
    Hommel E, Mathiesen E, Edsberg B, Bahnsen M, Parving H-H: Acute reduction of arterial blood pressure reduces urinary albumin excretion in type 1 (insulin-dependent) diabetic patients with incipient nephropathy. Diabetologia 29: 211–215, 1986.PubMedCrossRefGoogle Scholar
  7. 7.
    Azar S, Mauer SM, Azar P: Effect of mesangial expansion on renal hemodynamics and auto-regulation of renal blood flow [abstr]. Kidney !nt 25: 209, 1984.Google Scholar
  8. 8.
    Parving H-H, Oxenbell B, Svendsen PAa, Christiansen JS, Andersen AR: Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 100: 550–555, 1982.Google Scholar
  9. 9.
    Viberti GC, Hill RD, Jarrett RJ, Argyropaulos A, Mahmud Y, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1: 1430–1432, 1982.PubMedCrossRefGoogle Scholar
  10. 10.
    Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311: 89–93, 1984.PubMedCrossRefGoogle Scholar
  11. 11.
    Mathiesen ER, Oxenbell B, Johansen K, Svendsen PAa, Deckert T: Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 26: 406–410, 1984.PubMedCrossRefGoogle Scholar
  12. 12.
    Hricik DE, Browning PJ, Koppelman R, Goorno WE, Madias NE, Dzau VJ: (1983) Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenosis or renal-artery stenosis in a solitary kidney. N Engl J Med 308: 373–376, 1983.Google Scholar
  13. 13.
    Curtis JJ, Luke RG, Whetchel JD, Diethelm AD, Jones P, Dustan HR: Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension. N Engl J Med 308: 377–381, 1983.PubMedCrossRefGoogle Scholar
  14. 14.
    Blythe WB: Captopril and renal autoregulation. N Engl J Med 308: 390–391, 1983.PubMedCrossRefGoogle Scholar
  15. 15.
    Bohrer MP, Dean WM, Robertson CR, Brenner BM: Mechanism of angiotensin Il-induced proteinuria in the rat. Am J Physiol 233: F13–21, 1977.PubMedGoogle Scholar
  16. 16.
    Taguma Y, Kilamoto Y, Futaki G, Ueda H, Momma H, Ishizaki M, Takahashi H, Sekino H, Sasaki Y: Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 313: 1617–1620, 1985.PubMedCrossRefGoogle Scholar
  17. 17.
    Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M: Beneficial effects on angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293: 471–474, 1986.CrossRefGoogle Scholar
  18. 18.
    Hommel E, Parving H-H, Mathiesen E, Edsberg B, Nielsen MD, Giese J: Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 293: 467–470, 1986.CrossRefGoogle Scholar
  19. 19.
    O’Hare JA: Effect of captopril on diabetic proteinuria [letter]. N Engl J Med 315: 515, 1986.CrossRefGoogle Scholar
  20. 20.
    Sridhar CB: Effect of captopril on diabetic proteinuria [letter] N Engl J Med 315: 515, 1986.Google Scholar
  21. 21.
    Arisz L, Donker AJM, Brentjens JRH, van der Hem GN: The effect of indomethacin on proteinuria and kidney function in the nephrotic syndrome. Acta Med Scand 199: 121–125, 1976.PubMedCrossRefGoogle Scholar
  22. 22.
    Kimberly RP, Gill JR, Bowden RE, Keiser HR, Plotz PH: Elevated urinary prostaglandins and the effect of aspirin on renal function in lupus erythematosus. Ann Intern Med 89: 336–341, 1978.PubMedGoogle Scholar
  23. 23.
    Tiggeler RGWL, Hulme B, Wifdeveld PGAB: Effect of indomethacin on glomerular permeability in the nephrotic syndrome. Kidney Int 16: 312–321, 1979.PubMedCrossRefGoogle Scholar
  24. 24.
    Ciabattoni G, Cinotti GA, Pierucci A, Simonetti BM, Manzi M, Pugliese F, Barsotti P, Pecci G, Taggi F, Patrono C: Effects of sulindac and ibuprofen in patients with chronic glomerular disease. N Engl J Med 310: 279–283, 1984.PubMedCrossRefGoogle Scholar
  25. 25.
    Hommel E, Mathiesen E, Arnold-Larsen S, Edsberg B, Olsen UB, Parving H-H: Effects of indomethacin on kidney function in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 30: 78–81, 1987.PubMedGoogle Scholar
  26. 26.
    Mathiesen ER, Hommel E, Olsen UB, Parving H-H: Effects of indomethacin on kidney function in insulin-dependent diabetic patients with incipient nephropathy [abstr]. Diabetologia 29: 569A, 1986.Google Scholar
  27. 27.
    Jensen PK, Steven K, Blæhr H, Christiansen JS, Parving H-H: Effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int 29: 490–495, 1986.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1988

Authors and Affiliations

  • Hans-Henrik Parving
  • Eva Hommel
  • Elisabeth Mathiesen

There are no affiliations available

Personalised recommendations